CLINICAL_TRIALS
trial_result
· 2024-11-08
Clinical Trial Update: A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis [Phase 2]
Summary
This clinical trial update reports results from a Phase 2 study of ocrelizumab in children and adolescents with relapsing-remitting multiple sclerosis. Results …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-11-08